Market Update: HSI extends loss, down 0.04%

The Hang Seng Index extended its recent losses, closeing down marginally by 0.04% or 11.29 points to end at 28,941.54 on Tuesday. This comes as investors await comments from the policy meeting of the US Federal Reserve.

Bottom performers for the day were Wuxi Biologics (Cayman) with $107.90 or 6.01% in loss, Budweiser which went lower by 1.8% or $24.60, and Link REIT which declined 1.35% or $73.25.

The Tech Index, however, gained further as it went higher by 0.37% or 31.21 points to close the day at 8,516.45.

Other Asian stocks traded mixed as the resurgence of COVID-19 cases and the US Federal Reserve policy meeting kept investors on edge.

Meanwhile, Wall Street benchmark indexes end mostly flat as investors await a batch of earnings from tech heavyweights.

S&P 500 decreased 0.02% or 0.90 points to end at 4,186.72, whilst NASDAQ edged down 0.34% or 48.56 points to end at 14,090.22. On the other hand, the Dow Jones Industrial inched up 0.01% or 3.36 points to close at 33,984.93.

London stocks closed the day in red, as investors monitor the COVID-19 crisis in India and amidst earnings season.

FTSE 100 fell 0.26% or 18.15 points to end at 6,944.97 despite the rise in bank shares, whilst the FTSE 250 slipped 0.64% or 144.26 points to close at 22,433.08.

 

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Hong Kong Residency rule could boost office sector
The ultra-rich are also expected to set up family offices in the city.
Allegrow Biotech engineers technology to activate immune cells
The startup’s invention can be used to treat and potentially cure diseases like cancer.
Healthcare
Renminbi rise to fuel Bank of China HK’s growth
The lender expects the currency to be used more often in cross-border deals.
Retail Banking